Health Canada inspection
Swedish Orphan Biovitrum AB: Health Canada inspection of Jun 26, 2026
Health Canada · GVP · rating C
Key facts
| Establishment | Swedish Orphan Biovitrum AB |
|---|---|
| City | Stockholm |
| Province | Stockholms Län |
| Country | Sweden |
| Program | GVP |
| Start date | Jun 23, 2026 |
| End date | Jun 26, 2026 |
| Rating | C |
| Rating description | Compliant |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: